Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Chételat G, et al. Among authors: law i. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. Lancet Neurol. 2020. PMID: 33098804 Review.
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K; European Association of Nuclear Medicine Neuroimaging Committee. Varrone A, et al. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2103-10. doi: 10.1007/s00259-009-1264-0. Eur J Nucl Med Mol Imaging. 2009. PMID: 19838705
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ. Vandenberghe R, et al. Among authors: law i. Ann Neurol. 2010 Sep;68(3):319-29. doi: 10.1002/ana.22068. Ann Neurol. 2010. PMID: 20687209 Clinical Trial.
FDG PET/CT imaging in canine cancer patients.
Hansen AE, McEvoy F, Engelholm SA, Law I, Kristensen AT. Hansen AE, et al. Among authors: law i. Vet Radiol Ultrasound. 2011 Mar-Apr;52(2):201-6. doi: 10.1111/j.1740-8261.2010.01757.x. Epub 2010 Oct 26. Vet Radiol Ultrasound. 2011. PMID: 21388475
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
Dunkl V, Cleff C, Stoffels G, Judov N, Sarikaya-Seiwert S, Law I, Bøgeskov L, Nysom K, Andersen SB, Steiger HJ, Fink GR, Reifenberger G, Shah NJ, Coenen HH, Langen KJ, Galldiks N. Dunkl V, et al. Among authors: law i. J Nucl Med. 2015 Jan;56(1):88-92. doi: 10.2967/jnumed.114.148734. Epub 2014 Dec 18. J Nucl Med. 2015. PMID: 25525183 Free article.
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chételat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata' S, Payoux P, Pagani M; European Association of Nuclear Medicine. Morbelli S, et al. Among authors: law i. Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1487-91. doi: 10.1007/s00259-015-3098-2. Eur J Nucl Med Mol Imaging. 2015. PMID: 26067090 Review. No abstract available.
Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.
Bailey DL, Pichler BJ, Gückel B, Barthel H, Beer AJ, Bremerich J, Czernin J, Drzezga A, Franzius C, Goh V, Hartenbach M, Iida H, Kjaer A, la Fougère C, Ladefoged CN, Law I, Nikolaou K, Quick HH, Sabri O, Schäfer J, Schäfers M, Wehrl HF, Beyer T. Bailey DL, et al. Among authors: law i. Mol Imaging Biol. 2015 Oct;17(5):595-608. doi: 10.1007/s11307-015-0886-9. Mol Imaging Biol. 2015. PMID: 26286794 Review.
Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, Visser PJ. Zwan MD, et al. Among authors: law i. Neurology. 2016 Jan 5;86(1):50-8. doi: 10.1212/WNL.0000000000002081. Epub 2015 Oct 14. Neurology. 2016. PMID: 26468410 Free PMC article.
408 results